Sign In
Buy NVO
$48.03
+0.385 (+0.81%)
At Close: Jun 26, 2026
Novo Nordisk membership in UK pharma body restored after suspension
11:17am, Monday, 17'th Mar 2025
Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two-year suspension for breaching a national drugmakers practice code.
Why Novo Nordisk (NVO) is a Top Stock for the Long-Term
10:31am, Monday, 17'th Mar 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Novo Nordisk A/S (NVO) Shareholders
10:30am, Monday, 17'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 17, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws,
Here is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending Stock
10:05am, Monday, 17'th Mar 2025
Zacks.com users have recently been watching Novo Nordisk (NVO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
NEW YORK, NY / ACCESS Newswire / March 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Novo Nordi
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NVO
09:45am, Monday, 17'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 17, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws,
Novo Nordisk A/S Investors: March 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
09:10am, Monday, 17'th Mar 2025
SAN FRANCISCO, CA / ACCESS Newswire / March 17, 2025 / National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Novo Nordisk A/S. ("Novo" or the "Company") (NYSE:NV
Shareholders of Novo Nordisk A/S Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - NVO
08:00am, Monday, 17'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 17, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws,
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
06:47am, Monday, 17'th Mar 2025
Are you reluctant to invest in stocks right now? That's understandable.
Class Action Filed Against Novo Nordisk A/S (NVO) - March 25, 2025 Deadline to Join - Contact The Gross Law Firm
05:45am, Monday, 17'th Mar 2025
NEW YORK , March 17, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A/S (NYSE: NVO). Shareholders who purchased shares of NVO during the class per
Class Action Filed Against Novo Nordisk A/S (NVO) - March 25, 2025 Deadline to Join - Contact Levi & Korsinsky
10:00pm, Sunday, 16'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 16, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws,
SAN FRANCISCO, March 16, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk A/S (NYSE: NVO) is facing a class-action lawsuit from investors who allege the pharmaceutical giant misled them about the prospects of it
NVO LAWSUIT ALERT: Levi & Korsinsky Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline
07:00pm, Sunday, 16'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 16, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws,
NVO LAWSUIT ALERT: Levi & Korsinsky Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline
02:13pm, Sunday, 16'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 16, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws,
NEW YORK CITY, NY / ACCESS Newswire / March 16, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022
